Univet Vetinary Pharmaceuticals

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40028434

Informations générales

Localisation

Ireland

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

SME

Dernière mise à jour

08/01/2026

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2035

Statut

Targets set

Classification

1.5°C

Année cible

2035

Progression vers l'objectif55%
2015 (année de référence)2035
Description complète des objectifs

This target was approved using a streamlined target validation route exclusive to small and medium-sized enterprises (SMEs). https://docs.sbtiservices.com/resources/FAQsforSMEs.pdf Univet Vetinary Pharmaceuticals commits to reduce absolute scope 1 and scope 2 GHG emissions 63% by 2035 from a 2024 base year, and to measure and reduce its scope 3 emissions.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques